LEPROT and cancer: Results show that the level of LEPROT was consistently positively correlated with that of JAK1, JAK2, and STAT3 (Figure 3B), which suggested that JAK1/2/STAT3 might be the downstream LEPROT and mediate cancer cell proliferation and TME alterations.